IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,842 | +127966.7% | 82 | -2.4% | 0.00% | +100.0% |
Q4 2022 | $3 | -99.9% | 84 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $4,000 | -96.3% | 84 | -96.4% | 0.00% | -95.5% |
Q2 2022 | $107,000 | +12.6% | 2,327 | -9.6% | 0.04% | +18.9% |
Q1 2022 | $95,000 | +13.1% | 2,574 | -7.2% | 0.04% | +19.4% |
Q4 2021 | $84,000 | -27.0% | 2,775 | -19.1% | 0.03% | -22.5% |
Q3 2021 | $115,000 | -23.8% | 3,431 | -9.4% | 0.04% | -16.7% |
Q2 2021 | $151,000 | -16.6% | 3,786 | -6.0% | 0.05% | -25.0% |
Q1 2021 | $181,000 | +8950.0% | 4,028 | +10228.2% | 0.06% | +6300.0% |
Q4 2020 | $2,000 | 0.0% | 39 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $2,000 | 0.0% | 39 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $2,000 | 0.0% | 39 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $2,000 | 0.0% | 39 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $2,000 | 0.0% | 39 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $2,000 | -33.3% | 39 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $3,000 | 0.0% | 39 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $3,000 | +50.0% | 39 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $2,000 | – | 39 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |